• レポートコード:MRC2012A3384 • 出版社/出版日:GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、109ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:医薬品、医療 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、寄生虫駆除剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。寄生虫駆除剤の種類別市場規模(耳札、錠剤、注射剤、飼料添加物)、用途別市場規模(獣医病院/クリニック、動物農場、在宅医療環境)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Boehringer Ingelheim、Bayer AG、Merck、Elanco、Ceva Sante Animlae、Zoetis、Vetoquinol、Novartis AG、Virbac、Eli Lilly ・地域別グローバル市場分析 2015年-2020年 ・寄生虫駆除剤の北米市場(アメリカ、カナダ、メキシコ) ・寄生虫駆除剤のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア) ・寄生虫駆除剤のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア) ・寄生虫駆除剤の南米市場(ブラジル、アルゼンチン) ・寄生虫駆除剤の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ) ・種類別分析:耳札、錠剤、注射剤、飼料添加物 ・用途別分析:獣医病院/クリニック、動物農場、在宅医療環境 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Endoparasiticide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Endoparasiticide market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Endoparasiticide market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Endoparasiticide market has been segmented into
Ear Tags
Tablets
Injectables
Feed Additives
By Application, Endoparasiticide has been segmented into:
Veterinary Hospitals or Clinics
Animal Farms
Home Care Settings
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Endoparasiticide market presented in the report. This section sheds light on the sales growth of different regional and country-level Endoparasiticide markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Endoparasiticide market.
The report offers in-depth assessment of the growth and other aspects of the Endoparasiticide market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Endoparasiticide Market Share Analysis
Endoparasiticide competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Endoparasiticide sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Endoparasiticide sales, revenue and market share for each player covered in this report.
The major players covered in Endoparasiticide are:
Boehringer Ingelheim
Bayer AG
Merck
Elanco
Ceva Sante Animlae
Zoetis
Vetoquinol
Novartis AG
Virbac
Eli Lilly
Among other players domestic and global, Endoparasiticide market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Endoparasiticide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Endoparasiticide, with price, sales, revenue and global market share of Endoparasiticide in 2018 and 2019.
Chapter 3, the Endoparasiticide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Endoparasiticide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Endoparasiticide market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Endoparasiticide sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Endoparasiticide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Endoparasiticide Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Ear Tags
1.2.3 Tablets
1.2.4 Injectables
1.2.5 Feed Additives
1.3 Market Analysis by Application
1.3.1 Overview: Global Endoparasiticide Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Veterinary Hospitals or Clinics
1.3.3 Animal Farms
1.3.4 Home Care Settings
1.4 Overview of Global Endoparasiticide Market
1.4.1 Global Endoparasiticide Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim SWOT Analysis
2.1.4 Boehringer Ingelheim Product and Services
2.1.5 Boehringer Ingelheim Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer AG
2.2.1 Bayer AG Details
2.2.2 Bayer AG Major Business
2.2.3 Bayer AG SWOT Analysis
2.2.4 Bayer AG Product and Services
2.2.5 Bayer AG Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Elanco
2.4.1 Elanco Details
2.4.2 Elanco Major Business
2.4.3 Elanco SWOT Analysis
2.4.4 Elanco Product and Services
2.4.5 Elanco Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ceva Sante Animlae
2.5.1 Ceva Sante Animlae Details
2.5.2 Ceva Sante Animlae Major Business
2.5.3 Ceva Sante Animlae SWOT Analysis
2.5.4 Ceva Sante Animlae Product and Services
2.5.5 Ceva Sante Animlae Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Zoetis
2.6.1 Zoetis Details
2.6.2 Zoetis Major Business
2.6.3 Zoetis Product and Services
2.6.4 Zoetis Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Vetoquinol
2.7.1 Vetoquinol Details
2.7.2 Vetoquinol Major Business
2.7.3 Vetoquinol Product and Services
2.7.4 Vetoquinol Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business
2.8.3 Novartis AG Product and Services
2.8.4 Novartis AG Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Virbac
2.9.1 Virbac Details
2.9.2 Virbac Major Business
2.9.3 Virbac Product and Services
2.9.4 Virbac Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Product and Services
2.10.4 Eli Lilly Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Endoparasiticide Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Endoparasiticide Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Endoparasiticide Manufacturer Market Share in 2019
3.3.2 Top 6 Endoparasiticide Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Endoparasiticide Sales, Revenue and Market Share by Regions
4.1.1 Global Endoparasiticide Sales and Market Share by Regions (2015-2020)
4.1.2 Global Endoparasiticide Revenue and Market Share by Regions (2015-2020)
4.2 North America Endoparasiticide Sales and Growth Rate (2015-2020)
4.3 Europe Endoparasiticide Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Endoparasiticide Sales and Growth Rate (2015-2020)
4.5 South America Endoparasiticide Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Endoparasiticide Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Endoparasiticide Sales, Revenue and Market Share by Country
5.1.1 North America Endoparasiticide Sales and Market Share by Country (2015-2020)
5.1.2 North America Endoparasiticide Revenue and Market Share by Country (2015-2020)
5.2 United States Endoparasiticide Sales and Growth Rate (2015-2020)
5.3 Canada Endoparasiticide Sales and Growth Rate (2015-2020)
5.4 Mexico Endoparasiticide Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Endoparasiticide Sales, Revenue and Market Share by Country
6.1.1 Europe Endoparasiticide Sales and Market Share by Country (2015-2020)
6.1.2 Europe Endoparasiticide Revenue and Market Share by Country (2015-2020)
6.2 Germany Endoparasiticide Sales and Growth Rate (2015-2020)
6.3 UK Endoparasiticide Sales and Growth Rate (2015-2020)
6.4 France Endoparasiticide Sales and Growth Rate (2015-2020)
6.5 Russia Endoparasiticide Sales and Growth Rate (2015-2020)
6.6 Italy Endoparasiticide Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Endoparasiticide Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Endoparasiticide Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Endoparasiticide Revenue and Market Share by Regions (2015-2020)
7.2 China Endoparasiticide Sales and Growth Rate (2015-2020)
7.3 Japan Endoparasiticide Sales and Growth Rate (2015-2020)
7.4 Korea Endoparasiticide Sales and Growth Rate (2015-2020)
7.5 India Endoparasiticide Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Endoparasiticide Sales and Growth Rate (2015-2020)
7.7 Australia Endoparasiticide Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Endoparasiticide Sales, Revenue and Market Share by Country
8.1.1 South America Endoparasiticide Sales and Market Share by Country (2015-2020)
8.1.2 South America Endoparasiticide Revenue and Market Share by Country (2015-2020)
8.2 Brazil Endoparasiticide Sales and Growth Rate (2015-2020)
8.3 Argentina Endoparasiticide Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Endoparasiticide Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Endoparasiticide Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Endoparasiticide Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Endoparasiticide Sales and Growth Rate (2015-2020)
9.3 Turkey Endoparasiticide Sales and Growth Rate (2015-2020)
9.4 Egypt Endoparasiticide Sales and Growth Rate (2015-2020)
9.5 South Africa Endoparasiticide Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Endoparasiticide Sales and Market Share by Type (2015-2020)
10.2 Global Endoparasiticide Revenue and Market Share by Type (2015-2020)
10.3 Global Endoparasiticide Price by Type (2015-2020)
11 Global Endoparasiticide Market Segment by Application
11.1 Global Endoparasiticide Sales Market Share by Application (2015-2020)
11.2 Global Endoparasiticide Revenue Market Share by Application (2015-2020)
11.3 Global Endoparasiticide Price by Application (2015-2020)
12 Market Forecast
12.1 Global Endoparasiticide Sales, Revenue and Growth Rate (2021-2025)
12.2 Endoparasiticide Market Forecast by Regions (2021-2025)
12.2.1 North America Endoparasiticide Market Forecast (2021-2025)
12.2.2 Europe Endoparasiticide Market Forecast (2021-2025)
12.2.3 Asia-Pacific Endoparasiticide Market Forecast (2021-2025)
12.2.4 South America Endoparasiticide Market Forecast (2021-2025)
12.2.5 Middle East & Africa Endoparasiticide Market Forecast (2021-2025)
12.3 Endoparasiticide Market Forecast by Type (2021-2025)
12.3.1 Global Endoparasiticide Sales Forecast by Type (2021-2025)
12.3.2 Global Endoparasiticide Market Share Forecast by Type (2021-2025)
12.4 Endoparasiticide Market Forecast by Application (2021-2025)
12.4.1 Global Endoparasiticide Sales Forecast by Application (2021-2025)
12.4.2 Global Endoparasiticide Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Endoparasiticide Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Endoparasiticide by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Endoparasiticide Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Endoparasiticide Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer Ingelheim Endoparasiticide Major Business
Table 10. Boehringer Ingelheim Endoparasiticide Total Revenue (USD Million) (2018-2019)
Table 11. Boehringer Ingelheim SWOT Analysis
Table 12. Boehringer Ingelheim Endoparasiticide Product and Services
Table 13. Boehringer Ingelheim Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 15. Bayer AG Endoparasiticide Major Business
Table 16. Bayer AG Endoparasiticide Total Revenue (USD Million) (2018-2019)
Table 17. Bayer AG SWOT Analysis
Table 18. Bayer AG Endoparasiticide Product and Services
Table 19. Bayer AG Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Merck Basic Information, Manufacturing Base and Competitors
Table 21. Merck Endoparasiticide Major Business
Table 22. Merck Endoparasiticide Total Revenue (USD Million) (2018-2019)
Table 23. Merck SWOT Analysis
Table 24. Merck Endoparasiticide Product and Services
Table 25. Merck Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Elanco Basic Information, Manufacturing Base and Competitors
Table 27. Elanco Endoparasiticide Major Business
Table 28. Elanco Endoparasiticide Total Revenue (USD Million) (2018-2019)
Table 29. Elanco SWOT Analysis
Table 30. Elanco Endoparasiticide Product and Services
Table 31. Elanco Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Ceva Sante Animlae Basic Information, Manufacturing Base and Competitors
Table 33. Ceva Sante Animlae Endoparasiticide Major Business
Table 34. Ceva Sante Animlae Endoparasiticide Total Revenue (USD Million) (2018-2019)
Table 35. Ceva Sante Animlae SWOT Analysis
Table 36. Ceva Sante Animlae Endoparasiticide Product and Services
Table 37. Ceva Sante Animlae Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Zoetis Basic Information, Manufacturing Base and Competitors
Table 39. Zoetis Endoparasiticide Major Business
Table 40. Zoetis Endoparasiticide Total Revenue (USD Million) (2018-2019)
Table 41. Zoetis SWOT Analysis
Table 42. Zoetis Endoparasiticide Product and Services
Table 43. Zoetis Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Vetoquinol Basic Information, Manufacturing Base and Competitors
Table 45. Vetoquinol Endoparasiticide Major Business
Table 46. Vetoquinol Endoparasiticide Total Revenue (USD Million) (2018-2019)
Table 47. Vetoquinol SWOT Analysis
Table 48. Vetoquinol Endoparasiticide Product and Services
Table 49. Vetoquinol Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 51. Novartis AG Endoparasiticide Major Business
Table 52. Novartis AG Endoparasiticide Total Revenue (USD Million) (2018-2019)
Table 53. Novartis AG SWOT Analysis
Table 54. Novartis AG Endoparasiticide Product and Services
Table 55. Novartis AG Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Virbac Basic Information, Manufacturing Base and Competitors
Table 57. Virbac Endoparasiticide Major Business
Table 58. Virbac Endoparasiticide Total Revenue (USD Million) (2018-2019)
Table 59. Virbac SWOT Analysis
Table 60. Virbac Endoparasiticide Product and Services
Table 61. Virbac Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 63. Eli Lilly Endoparasiticide Major Business
Table 64. Eli Lilly Endoparasiticide Total Revenue (USD Million) (2018-2019)
Table 65. Eli Lilly SWOT Analysis
Table 66. Eli Lilly Endoparasiticide Product and Services
Table 67. Eli Lilly Endoparasiticide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Global Endoparasiticide Sales by Manufacturer (2018-2019) (K Units)
Table 69. Global Endoparasiticide Revenue by Manufacturer (2018-2019) (USD Million)
Table 70. Global Endoparasiticide Sales by Regions (2015-2020) (K Units)
Table 71. Global Endoparasiticide Sales Market Share by Regions (2015-2020)
Table 72. Global Endoparasiticide Revenue by Regions (2015-2020) (USD Million)
Table 73. North America Endoparasiticide Sales by Countries (2015-2020) (K Units)
Table 74. North America Endoparasiticide Sales Market Share by Countries (2015-2020)
Table 75. North America Endoparasiticide Revenue by Countries (2015-2020) (USD Million)
Table 76. North America Endoparasiticide Revenue Market Share by Countries (2015-2020)
Table 77. Europe Endoparasiticide Sales by Countries (2015-2020) (K Units)
Table 78. Europe Endoparasiticide Sales Market Share by Countries (2015-2020)
Table 79. Europe Endoparasiticide Revenue by Countries (2015-2020) (USD Million)
Table 80. Asia-Pacific Endoparasiticide Sales by Regions (2015-2020) (K Units)
Table 81. Asia-Pacific Endoparasiticide Sales Market Share by Regions (2015-2020)
Table 82. Asia-Pacific Endoparasiticide Revenue by Regions (2015-2020) (USD Million)
Table 83. South America Endoparasiticide Sales by Countries (2015-2020) (K Units)
Table 84. South America Endoparasiticide Sales Market Share by Countries (2015-2020)
Table 85. South America Endoparasiticide Revenue by Countries (2015-2020) (USD Million)
Table 86. South America Endoparasiticide Revenue Market Share by Countries (2015-2020)
Table 87. Middle East & Africa Endoparasiticide Sales by Countries (2015-2020) (K Units)
Table 88. Middle East & Africa Endoparasiticide Sales Market Share by Countries (2015-2020)
Table 89. Middle East & Africa Endoparasiticide Revenue by Countries (2015-2020) (USD Million)
Table 90. Middle East & Africa Endoparasiticide Revenue Market Share by Countries (2015-2020)
Table 91. Global Endoparasiticide Sales by Type (2015-2020) (K Units)
Table 92. Global Endoparasiticide Sales Share by Type (2015-2020)
Table 93. Global Endoparasiticide Revenue by Type (2015-2020) (USD Million)
Table 94. Global Endoparasiticide Revenue Share by Type (2015-2020)
Table 95. Global Endoparasiticide Sales by Application (2015-2020) (K Units)
Table 96. Global Endoparasiticide Sales Share by Application (2015-2020)
Table 97. Global Endoparasiticide Sales Forecast by Regions (2021-2025) (K Units)
Table 98. Global Endoparasiticide Market Share Forecast by Regions (2021-2025)
Table 99. Global Endoparasiticide Sales Forecast by Type (2021-2025) (K Units)
Table 100. Global Endoparasiticide Market Share Forecast by Type (2021-2025)
Table 101. Global Endoparasiticide Sales Forecast by Application (2021-2025)
Table 102. Global Endoparasiticide Market Share Forecast by Application (2021-2025)
Table 103. Direct Channel Pros & Cons
Table 104. Indirect Channel Pros & Cons
Table 105. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Endoparasiticide Picture
Figure 2. Global Sales Market Share of Endoparasiticide by Type in 2019
Figure 3. Ear Tags Picture
Figure 4. Tablets Picture
Figure 5. Injectables Picture
Figure 6. Feed Additives Picture
Figure 7. Endoparasiticide Sales Market Share by Application in 2019
Figure 8. Veterinary Hospitals or Clinics Picture
Figure 9. Animal Farms Picture
Figure 10. Home Care Settings Picture
Figure 11. Global Endoparasiticide Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Endoparasiticide Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Endoparasiticide Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Endoparasiticide Sales Market Share by Manufacturer in 2019
Figure 32. Global Endoparasiticide Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Endoparasiticide Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Endoparasiticide Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Endoparasiticide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Endoparasiticide Revenue Market Share by Regions (2015-2020)
Figure 39. Global Endoparasiticide Revenue Market Share by Regions in 2018
Figure 40. North America Endoparasiticide Sales and Growth Rate (2015-2020)
Figure 41. Europe Endoparasiticide Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Endoparasiticide Sales and Growth Rate (2015-2020)
Figure 43. South America Endoparasiticide Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Endoparasiticide Sales and Growth Rate (2015-2020)
Figure 45. North America Endoparasiticide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Endoparasiticide Sales Market Share by Countries (2015-2020)
Figure 47. North America Endoparasiticide Sales Market Share by Countries in 2018
Figure 48. North America Endoparasiticide Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Endoparasiticide Revenue Market Share by Countries in 2018
Figure 50. United States Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Endoparasiticide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Endoparasiticide Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Endoparasiticide Revenue Market Share by Countries in 2019
Figure 56. Germany Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Endoparasiticide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Endoparasiticide Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Endoparasiticide Revenue Market Share by Regions 2019
Figure 64. China Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Endoparasiticide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Endoparasiticide Sales Market Share by Countries in 2019
Figure 71. South America Endoparasiticide Revenue Market Share by Countries in 2019
Figure 72. Brazil Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Endoparasiticide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Endoparasiticide Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Endoparasiticide Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Endoparasiticide Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Endoparasiticide Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Endoparasiticide Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Endoparasiticide Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Endoparasiticide Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Endoparasiticide Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Endoparasiticide Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Endoparasiticide Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Endoparasiticide Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel